Rational prescribing for postmenopausal urogenital complaints

Drugs and Aging

Volumn 9, Issue 2, 1996, Pages 78-86

  Milsom, Ian ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ESTRIOL; ESTROGEN; QUINESTRADOL;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; DRUG COST; DYSPAREUNIA; DYSURIA; ESTROGEN THERAPY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MORBIDITY; NOCTURIA; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SOCIOECONOMICS; URGE INCONTINENCE; URINARY TRACT INFECTION; URINE INCONTINENCE; UROGENITAL TRACT DISEASE; VAGINA DISEASE; VAGINA FLORA;

EID: 0029761585     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199609020-00002     Document Type: Review

References (59)

1. Iosif CS, Henriksson L, Ulmsten U. The frequency of disorders of the lower urinary trace, urinary incontinence in particular, as evaluated by a questionnaire survey in a gynecological health control population. Acta Obstet Gynecol Scand 1981; 60: 71-6
2. Iosif C, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984; 63: 257-60
3. Hagstad A, Janson P-O. The epidemiology of climacteric symptoms. Acta Obstet Gynecol Scand Suppl 1986; 134: 59-65
4. Berg G, Gottqall T, Hammar M, et al. Climacteric symptoms among women aged 60-62 in Linköping, Sweden, in 1986. Maturitas 1988; 10: 193-9
5. Molander U, Milsom I, Ekelund P, et al. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas 1990; 12: 51-60
6. Grimby A, Milsom I, Molander U, et al. The influence of urinary incontinence on the quality of life in elderly women. Age Ageing 1993; 22: 82-9
7. Milsom I, Ekelund P, Molander U, et al. The influence of age, parity, oral contraception, hysterectomy and the menopause on the prevalence of urinary incontinence in women. J Urol 1993; 149: 1459-62
8. Hellström L, Ekelund P, Milsom I, et al. The prevalence of urinary incontinence and use of incontinence aids in 85-year-old men and women. Age Ageing 1990; 19: 1-7
9. Norton PA, MacDonald LD, Sedgewich PM, et al. Distress and delay associated with urinary incontinence, frequency and urgency in women. BMJ 1988; 297: 1187-9
10. Hu T-W. Impact of urinary incontinence on health-care costs. J Am Geriatr Soc 1990; 38: 292-5
11. Ekelund P, Grimby A, Milsom I. Urinary incontinence: social and financial costs high [letter]. BMJ 1993; 306: 1344
12. Steel J, Fonda D. Minimising the cost of urinary incontinence in nursing homes. PharmacoEconomics 1995; 7: 191-7
13. Ekelund P, Rundgren Å. Urinary incontinence in the elderly with implications for hospital care consumption and social disability. Arch Geront Geriatr 1987; 6: 11-8
14. Sarrel PM. Sexuality in the middle years. Obstet Gynecol Clin North Am 1987; 14: 49-62
15. Bartlett JG, Onderdonk AB, Drude E, et al. Quantitative bacteriology of the vaginal flora. J Infect Dis 1977; 136: 271-7
16. Osborne NG, Wright RC, Grubin L. Genital bacteriology: a comparative study of premenopausal women with postmenopausal women. Am J Obstet Gynecol 1979; 135: 195-8
17. Milne JS. Prevalence of incontinence in the elderly age groups. In: Willington FL, editor. Incontinence in the elderly. London: Academic Press, 1976
18. Brocklehurst JC, Dillane JB, Griffiths L, et al. The prevalence and symptomatology of urinary infection in an aged population. Geront Clin 1968; 10: 242-53
19. Brocklehurst JC, Fry J, Griffiths LL, et al. Dysuria in old age. J Am Geriatr Soc 1971; 19: 582-90
20. Feneley RC, Shephard AM, Powell PH, et al. Urinary incontinence: prevalence and needs. Br J Urol 1979; 51: 493-6
21. Thomas TM, Plymat KR, Blannin J, et al. Prevalence of urinary incontinence. BMJ 1980; 281: 1243-5
22. Ouslander JG, Kane RL, Abrass IB. Urinary incontinence in elderly nursing home patients. JAMA 1982; 248 (10): 1194-8
23. Campbell AJ, Reinken J, McCosh L. Incontinence in the elderly: prevalence and prognosis. Age Ageing 1985; 14: 65-70
24. Diokno AC, Brock BM, Brown MB, et al. Prevalence of urinary incontinence and other urological symptoms in the non-institutionalized elderly. J Urol 1986; 136: 1022-5
25. McGrother CW, Castleden CM, Duffin H, et al. A profile of disordered micturition in the elderly at home. Age Ageing 1987; 16: 105-10
26. Herzog AR, Brock BM, Fultz NH, et al. Urinary incontinence and psychological distress among older adults. Psychol Aging 1988; 3 (2): 115-21
27. Jolleys J. Reported prevalence of urinary incontinence in women in a general practice. BMJ 1988; 296: 1300-2
28. Elving LB, Foldspang A, Lam GW. et al. Descriptive epidemiology of urinary incontinence in 3,100 women age 30-59. Scand J Urol Nephrol Suppl 1989; 125: 37-43
29. Mäkinen JI, Grönroos M, Kiilholma PJA, et al. The prevalence of urinary incontinence in a randomized population of 5247 adult Finnish women. Int Urogynecol J 1992; 3: 110-3
30. Brocklehurst JC. Urinary incontinence in the community - analysis of a MORI poll. BMJ 1993; 306: 832-4
31. Nordqvist P, Ekelund P, Edouard L, et al. Catheter-free geriatric care: routines and consequences for clinical infection, care and economy. J Hosp Infect 1984; 5: 298-304
32. Brandberg Å, Mellström D, Persson U, et al. Urogenital oestrogen deficiency syndrome among women aged 65+: an assessment of the economics of its treatment. Institute for Health Economics (IHE) working paper 1991: I. Lund: Swedish Institute for Health Economics, 1991
33. McCue JD. Gram-negative bacillary bacteremia in the elderly: incidence, ecology, etiology and mortality. J Am Geriatr Soc 1987; 35: 213-8
34. Milsom I, Fall M, Ekelund P. Urininkontinens - en kostnadskrävande folksjukdom. Lakartidningen 1992; 89: 1772-4
35. Ingelman-Sundberg A, Rosén J, Gustafsson SA, et al. Cytosol estrogen receptors in the urogenital tissues in stress-incontinent women. Acta Obstet Gynecol Scand 1981; 60: 585-6
36. Iosif CS, Batra S, Ek A, et al. Estrogen receptors in the human lower urinary tract. Am J Obstet Gynecol 1981; 141: 817-20
37. Smith P, Heimer G, Norgren U, et al. Steroid hormone receptors in pelvic muscles and ligaments in women. Gynecol Obstet Invest 1990; 30: 27-30
38. Salmon UL, Walter RI, Gast SH. The use of estrogens in the treatment of dysuria and incontinence in postmenopausal women. Am J Obstet Gynecol 1941; 42: 845-7
39. Musiani U. A partially successful attempt at medical treatment of urinary stress incontinence in women. Urol Int 1972; 27: 405-10
40. Rud T. The effects of estrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women. Acta Obstet Gynecol Scand 1980; 59: 265-70
41. Judge TDG. The use of quinestradiol in elderly incontinent women: a preliminary report. Gerontol Clin 1969; 11: 159-64
42. Samsioe G, Jansson I, Mellström D, et al. The occurrence, nature and treatment of urinary incontinence in a 70 year old population. Maturitas 1985; 7: 335-42
43. Walter S, Wolf H, Barlebo H, et al. Urinary incontinence in postmenopausal women treated with estrogens: a double-blind clinical trial. Urol Int 1978; 33: 135-43
44. Molander U, Milsom I, Ekelund P, et al. A health care programme for the investigation and treatment of elderly women with urinary incontinence and related urogenital symptoms. Acta Obstel Gynecol Scand 1991; 70: 137-42
45. Cardozo L. Role of estrogens in the treatment of female urinary incontinence. J Am Geriatr Soc 1990; 38: 326-8
46. Fantl JA, Cardozo L, McClish DK, et al. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obslet Gynecol 1994; 83: 12-8
47. Kicovic PM, Cortes-Prieto J, Milojevic S, et al. The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects. Maturitas 1980; 2: 275-82
48. Mattsson L-Å, Cullberg G. A clinical evaluation of treatment with estriol vaginal cream versus suppository in post-menopausal women. Acta Obstet Gynecol Scand 1983; 62: 397-401
49. Brandberg Å, Mellström D, Samsioe G. Low dose oral estriol treatment in elderly women with urogenital infections. Acta Obstet Gynecol Scand Suppl 1987; 140: 33-8
50. Molander U, Milsom I, Ekelund P, et al. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas 1990; 12: 113-20
51. Nilsson K, Heimer G. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency - a pharmacokinetic and pharmacodynamic study. Maturitas 1992; 15: 121-7
52. Smith P, Heimer G, Lindskog M, et al. Estradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 1993; 16: 145-54
53. Henriksson L, Sternquist M, Boquist L, et al. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994; 171: 624-32
54. Milsom I, Nilsson LÅ, Brandberg Å, et al. Vaginal immunoglobulin A(IgA) levels in post-menopausal women: influence of oestriol therapy. Maturitas 1991; 13: 129-5
55. Stamey TA. The role of introital enterobacteria in recurrent urinary infections. J Urol 1973; 109: 467-72
56. Milsom I, Arvidsson L, Ekelund P, et al. Factors influencing vaginal cytology, pH and bacterial flora in elderly women. Acta Obstet Gynecol Scand 1993; 72: 286-91
57. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753-6
58. Stamm WE, Counts GW, McKevitt M, et al. Urinary prophylaxis with trimethoprim and trimethoprim-sulphamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control. Rev Infect Dis 1982; 4: 450-5
59. Nicolle LE, Harding GKM, Thompson M, et al. Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women. Antimicrob Agents Chemother 1989; 33: 1032-5